Continuous perfusion of pulmonary arteries during total cardiopulmonary bypass favorably affects levels of circulating adhesion molecules and lung function

Journal of Thoracic and Cardiovascular Surgery

Volumn 122, Issue 2, 2001, Pages 242-248

  Suzuki, Takaaki ^a,c   Ito, Tsutomu ^a   Kashima, Ichiro ^a   Teruya, Koji ^b   Fukuda, Toyoki ^a  

^a Tokyo Metropolitan Children's Hospital   (Japan)

^b KYORIN UNIVERSITY   (Japan)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; INTERCELLULAR ADHESION MOLECULE 1; PADGEM PROTEIN; SIALYL LEWIS X ANTIGEN;

ARTICLE; BLOOD FLOW; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; ENDOTHELIUM; HUMAN; INFANT; ISCHEMIA; LUNG FUNCTION; LUNG INJURY; LUNG PERFUSION; MICROVASCULATURE; NEUTROPHIL; OXYGEN TENSION; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION;

EID: 0035437436     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1067/mtc.2001.114779     Document Type: Article

References (21)

1. Koma H, Haworth SG. The effect of cardiopulmonary bypass on the lung. In: Jonas RA, Elliott MJ. editors. Cardiopulmonary Bypass in Neonates, Infants, and Young Children. Oxford: Butterworth-Heinemann Ltd; 1994. p. 242-62.
2. Kirklin JK, Westaby S, Blackstone EH, et al. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1983;86:845-57.
3. Frering B, Philip I, Dehoux M, et al. Circulating cytokines in patients undergoing normothermic cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1994;108:636-41.
4. Chenoweth DE, Cooper SW, Hugli TE, el al. Complement activation during cardiopulmonary bypass - evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med. 1981;304:497-503.
5. Horgan MJ, Wright SD, Malik AB. Antibody against leukocyle integrin (CD18) prevents reperfusion-induced lung vascular injury. Am J Physiol. 1990;259:L315-9.
6. Friedman M, Sellke FW, Wang SY, et al. Parameters of pulmonary injury after total or partial cardiopulmonary bypass. Circulation. 1994;90(Suppl):11-262-8.
7. Chai PJ, Williamson JA, Lodge AJ, et al. Effects of ischemia on pulmonary dysfunction after cardiopulmonary bypass. Ann Thorac Surg. 1999;67:731-5.
8. Suzuki T, Fukuda T, Ito T, et al. Continuous pulmonary perfusion during cardiopulmonary bypass prevents lung injury in infants. Ann Thorac Surg. 2000;69:602-6.
9. Serraf A, Rohotin M, Bonnet N, et al. Alteration of the neonatal pulmonary physiology after total cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1997;114:1061-9.
10. Asimakopoulos G, Taylor KM. Effects of cardiopulmonary bypass on leukocyte and endothelial adhesion molecules. Ann Thorac Surg. 1998;66:2135-44.
11. Springer TA. Adhesion receptors of the immune system. Nature. 1990;346:425-34.
12. Horgan MJ, Ge M, Gu J, et al. Role of ICAM-1 in neutrophil-mediated lung vascular injury after occlusion and reperfusion. Am J Physiol. 1991;261:H1578-84.
13. Gearing AJH, Newman W. Circulating adhesion molecules in disease. Immunol Today. 1993;14:506-12.
14. Cowley HC, Heney D, Gearing AJH, et al. Increased circulating adhesion molecule concentrations in patients with the systemic inflammatory response syndrome: A prospective cohort study. Crit Care Med. 1994;22:651-7.
15. Rothlein R, Mainolfi EA, Czajkowaki M, el al. A form of circulating ICAM-1 in human serum. J Immunol. 1991;147:3788-93.
16. Boldt J, Osmer C, Schindler E, et al. Circulating adhesion molecules in cardiac operations: Influence of high-dose aprotinin. Ann Thorac Surg. 1995;59:100-5.
17. Sakamaki F, Ishizaka A, Handa M, et al. Soluble form of P-selectin is elevated in acute lung injury. Am J Respir Crit Care Med. 1995;151:1821-6.
18. Gambte JR, Skinner MP, Berndt MC, et al. Prevention of activated neutrophil adhesion to endothelium by soluble adhesion protein GMP140. Science. 1990;249:414-7.
19. Boldt J, Kumle B, Papsdorf M, et al. Are circulating adhesion molecules specifically change in cardiac surgical patients? Ann Thorac Surg. 1998;65:608-14.
20. Ridings PC, Holloway S, Bloomfield GL, et al. Protective role of synthetic sialytated oligosaccharide in sepsis-induced acute lung, injury. J Appl Physiol. 1997;82:644-51.
21. Friedman M, Wang SY, Scllkc FW, et al. Neutrophil adhesion blockade with NPC 15669 decreases pulmonary injury after total cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1996;111:460-8.